Table 3.
In vivo studies of arsenic exposure and glucose metabolism.
Source | Experimental Animal | n | Compound (route) | Daily dose (ppm) | Duration | Outcomes and results (compared with controls) |
---|---|---|---|---|---|---|
Judd 1979 | Field mice | 19 | Methanearsonate (po in water) | 1,000 | 30 days | ↓ Blood glucose, = fluid and food consumption |
Ghafghazi et al. 1980 | Rats | 12 | Arsenite (ip) | 5–10 | 7 days | ↑ Glucose levels after glucose tolerance test, dose dependent |
Hughes and Thompson 1996 | B6C3F1 mice | 72 | Arsenate (po in water) | 0.025–2.5 | 28 days | ↓ Plasma glucose, = fluid and food consumption |
Aguilar et al. 1997 | Wistar rats | 20 | Arsenate (po in food) | 5 | 10 weeks | = Plasma glucose levels |
Cobo and Castineira 1997 | Wistar rats | 21 | Arsenite (po in water) | 17.75 | 1st week | Delayed glucose clearance after glucose tolerance test |
up to 100 | 8th week | = Basal insulin levels in vivo | ||||
Biswas et al. 2000 | Bengal goats | 12 | Arsenite (po in capsule) | 25 | 12 weeks | ↑ Blood glucose at week 6 and ↑↑ at week 12 |
Arnold et al. 2003 | Fischer rats | 480 | Monomethylarsenic (po in food) | 50–1,300 | 2 years | = Blood glucose levels up to 400 ppm, ↓with 1,300 ppm |
Pal and Chatterjee 2004a | Wistar rats | 18 | Arsenite (ip) | 5.55 | 21 days | ↓ Blood glucose (reversed with methionine)
= Body, liver, kidney weight |
Pal and Chatterjee 2004b | Wistar rats | 18 | Arsenite (ip) | 5.55 | 30 days | ↓ Blood glucose (reversed with N-acetylcysteine) |
Pal and Chatterjee 2005 | Wistar rats | 18 | Arsenite (ip) | 5.55 | 30 days | ↓ Blood glucose (reversed with methionine) |
Abbreviations: ip, intraperitoneal; po, per oral; ↑, increase; ↓, decrease.